Advertisement

Journal of Neuro-Oncology

, Volume 137, Issue 2, pp 387–394 | Cite as

Treatment and outcomes of 28 patients with spinal metastasis from gynecological cancer

  • Xin GaoEmail author
  • Chenglong Zhao
  • Shaohui He
  • Tianqi Fan
  • Wei Xu
  • Cheng Yang
  • Tielong LiuEmail author
  • Jianru XiaoEmail author
Clinical Study

Abstract

The aim of this study was to provide some useful information concerning clinical characteristics, surgical treatment, potential contributing factor and prognostic factors for patients with gynecological cancer (GC) spinal metastasis. We reviewed 28 patients with GC spinal metastasis in our spine tumor center between July 2008 and July 2015. Surgeries were performed on 22 of them. Univariate and multivariate analyses were conducted to identify potential prognostic factors affecting spinal metastasis-free survival (SMFS) and overall survival. The operative patients responded favorably according to decrease of VAS score and increase of Frankel grade after surgery. The 1- and 2-year survival rates in all patients were 60.7 and 41.0%, respectively. Univariate analysis suggested that age at diagnosis with GC was the potential contributing factor for spinal metastasis, while Frankel grade, ECOG-PS, visceral metastasis and chemotherapy were the potential prognostic factors affecting survival. Multivariate analysis indicated that the independent prognostic factors came from visceral metastasis and chemotherapy. Surgery played an important role in improving patients’ quality of life. Patients over 50 years old had a shorter SMFS after diagnosed with GC. Visceral metastasis was an adverse prognostic factor for patients with GC spinal metastasis, while chemotherapy was a favorable one.

Keywords

Gynecological cancer Spinal metastasis Surgery Spinal metastasis-free survival (SMFS) Overall survival (OS) Prognostic factors 

Notes

Compliance with ethical standards

Conflict of interest

All authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Siegel RL, Miller KD, Jemal A (2017) Cancer statistics, 2017. Cancer J Clin 67(1):7–30.  https://doi.org/10.3322/caac.21387 CrossRefGoogle Scholar
  2. 2.
    Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J (2016) Cancer statistics in China, 2015. Cancer J Clin 66(2):115–132.  https://doi.org/10.3322/caac.21338 CrossRefGoogle Scholar
  3. 3.
    Makino H, Nishio S, Tsubamoto H, Shimada M, Nishikawa R, Kai K, Ito K, Mizuno T, Ushijima K, Morishige KI (2016) Treatment and prognosis of bone metastasis from cervical cancer (KCOG-G1202s). J Obstet Gynaecol Res.  https://doi.org/10.1111/jog.12956 CrossRefPubMedGoogle Scholar
  4. 4.
    Yoon A, Choi CH, Kim HJ, Park JY, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG (2013) Contributing factors for bone metastasis in uterine cervical cancer. Int J Gynaecol Cancer 23(7):1311–1317.  https://doi.org/10.1097/IGC.0b013e31829da127 CrossRefGoogle Scholar
  5. 5.
    Thanapprapasr D, Nartthanarung A, Likittanasombut P, Na Ayudhya NI, Charakorn C, Udomsubpayakul U, Subhadarbandhu T, Wilailak S (2010) Bone metastasis in cervical cancer patients over a 10-year period. Int J Gynaecol Cancer 20(3):373–378.  https://doi.org/10.1111/IGC.0b013e3181d4a0a1 CrossRefGoogle Scholar
  6. 6.
    Yoon A, Choi CH, Kim TH, Choi JK, Park JY, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG (2014) Bone metastasis in primary endometrial carcinoma: features, outcomes, and predictors. Int J Gynaecol Cancer 24(1):107–112.  https://doi.org/10.1097/IGC.0000000000000015 CrossRefGoogle Scholar
  7. 7.
    Uccella S, Morris JM, Bakkum-Gamez JN, Keeney GL, Podratz KC, Mariani A (2013) Bone metastases in endometrial cancer: report on 19 patients and review of the medical literature. Gynecol Oncol 130(3):474–482.  https://doi.org/10.1016/j.ygyno.2013.05.010 CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Kehoe SM, Zivanovic O, Ferguson SE, Barakat RR, Soslow RA (2010) Clinicopathologic features of bone metastases and outcomes in patients with primary endometrial cancer. Gynecol Oncol 117(2):229–233.  https://doi.org/10.1016/j.ygyno.2010.01.047 CrossRefPubMedGoogle Scholar
  9. 9.
    Eskander JP, Kuris EO, Younghein AJ, Landsman S, Japko L, Eskander MS (2015) Spinal metastases from a primary fallopian tube serous adenocarcinoma: a case report. Glob Spine J 5(5):e65–e68.  https://doi.org/10.1055/s-0035-1546417 CrossRefGoogle Scholar
  10. 10.
    Zhang M, Sun J (2013) Bone metastasis from ovarian cancer. Clinical analysis of 26 cases. Saudi Med J 34(12):1270–1273PubMedGoogle Scholar
  11. 11.
    Patchell RA, Tibbs PA, Regine WF, Payne R, Saris S, Kryscio RJ, Mohiuddin M, Young B (2005) Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 366(9486):643–648.  https://doi.org/10.1016/S0140-6736(05)66954-1 CrossRefPubMedGoogle Scholar
  12. 12.
    Feiz-Erfan I, Rhines LD, Weinberg JS (2008) The role of surgery in the management of metastatic spinal tumors. Semin Oncol 35(2):108–117.  https://doi.org/10.1053/j.seminoncol.2007.12.005 CrossRefPubMedGoogle Scholar
  13. 13.
    Tang Y, Qu J, Wu J, Li S, Zhou Y, Xiao J (2015) Metastatic spinal cord compression from non-small-cell lung cancer treated with surgery and adjuvant therapies: a retrospective analysis of outcomes and prognostic factors in 116 patients. J Bone Joint Surg Am 97(17):1418–1425.  https://doi.org/10.2106/JBJS.N.01124 CrossRefPubMedGoogle Scholar
  14. 14.
    Zhang D, Xu W, Liu T, Yin H, Yang X, Wu Z, Xiao J (2013) Surgery and prognostic factors of patients with epidural spinal cord compression caused by hepatocellular carcinoma metastases: retrospective study of 36 patients in a single center. Spine 38(17):E1090–E1095.  https://doi.org/10.1097/BRS.0b013e3182983bf8 CrossRefPubMedGoogle Scholar
  15. 15.
    Han S, Wang T, Jiang D, Yu Y, Wang Y, Yan W, Xu W, Cheng M, Zhou W, Xiao J (2015) Surgery and survival outcomes of 30 patients with neurological deficit due to clear cell renal cell carcinoma spinal metastases. Eur Spine J 24(8):1786–1791.  https://doi.org/10.1007/s00586-015-3912-3 CrossRefPubMedGoogle Scholar
  16. 16.
    Liu A, Sankey EW, Goodwin CR, Kosztowski TA, Elder BD, Bydon A, Witham TF, Wolinsky JP, Gokaslan ZL, Sciubba DM (2016) Postoperative survival and functional outcomes for patients with metastatic gynecological cancer to the spine: case series and review of the literature. J Neurosurg Spine 24(1):131–144.  https://doi.org/10.3171/2015.3.SPINE15145 CrossRefPubMedGoogle Scholar
  17. 17.
    Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H, Akamaru T (2001) Surgical strategy for spinal metastases. Spine 26(3):298–306CrossRefGoogle Scholar
  18. 18.
    Tomita K, Kawahara N, Baba H, Tsuchiya H, Fujita T, Toribatake Y (1997) Total en bloc spondylectomy. A new surgical technique for primary malignant vertebral tumors. Spine 22(3):324–333CrossRefGoogle Scholar
  19. 19.
    Sun G, Li L, Jin P, Liu XW, Li M (2014) Percutaneous vertebroplasty for painful spinal metastasis with epidural encroachment. J Surg Oncol 110(2):123–128.  https://doi.org/10.1002/jso.23608 CrossRefPubMedGoogle Scholar
  20. 20.
    Rades D, Schild SE, Dunst J (2007) Radiotherapy is effective for metastatic spinal cord compression in patients with epithelial ovarian cancer. Int J Gynecol Cancer 17(1):263–265.  https://doi.org/10.1111/j.1525-1438.2006.00765.x CrossRefPubMedGoogle Scholar
  21. 21.
    Meng T, Chen R, Zhong N, Fan T, Li B, Yin H, Li Z, Zhou W, Song D, Xiao J (2016) Factors associated with improved survival following surgical treatment for metastatic prostate cancer in the spine: retrospective analysis of 29 patients in a single center. World J Surg Oncol 14(1):200.  https://doi.org/10.1186/s12957-016-0961-y CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Prasad D, Schiff D (2005) Malignant spinal-cord compression. Lancet Oncol 6(1):15–24.  https://doi.org/10.1016/S1470-2045(04)01709-7 CrossRefPubMedGoogle Scholar
  23. 23.
    Laufer I, Sciubba DM, Madera M, Bydon A, Witham TJ, Gokaslan ZL, Wolinsky JP (2012) Surgical management of metastatic spinal tumors. Cancer Control 19(2):122–128CrossRefGoogle Scholar
  24. 24.
    Quraishi NA, Rajagopal TS, Manoharan SR, Elsayed S, Edwards KL, Boszczyk BM (2013) Effect of timing of surgery on neurological outcome and survival in metastatic spinal cord compression. Eur Spine J 22(6):1383–1388.  https://doi.org/10.1007/s00586-012-2635-y CrossRefPubMedGoogle Scholar
  25. 25.
    Furstenberg CH, Wiedenhofer B, Gerner HJ, Putz C (2009) The effect of early surgical treatment on recovery in patients with metastatic compression of the spinal cord. J Bone Joint Surg Br 91(2):240–244.  https://doi.org/10.1302/0301-620X.91B2.20894 CrossRefPubMedGoogle Scholar
  26. 26.
    Chaichana KL, Woodworth GF, Sciubba DM, McGirt MJ, Witham TJ, Bydon A, Wolinsky JP, Gokaslan Z (2008) Predictors of ambulatory function after decompressive surgery for metastatic epidural spinal cord compression. Neurosurgery 62(3):683–692.  https://doi.org/10.1227/01.neu.0000317317.33365.15 (discussion 683–692).CrossRefPubMedGoogle Scholar
  27. 27.
    Nartthanarung A, Thanapprapasr K, Udomsubpayakul U, Thanapprapasr D (2014) Age and survival of cervical cancer patients with bone metastasis. Asian Pac J Cancer Prev 15(19):8401–8404CrossRefGoogle Scholar
  28. 28.
    Cho HW, Koo YJ, Hong JH, Lee JK (2017) Clinical indications for hysteroscopic removal of uterine masses: time, age at diagnosis, and mass size. J Obstet Gynaecol Res 43(11):1751–1757.  https://doi.org/10.1111/jog.13447 CrossRefPubMedGoogle Scholar
  29. 29.
    Campbell Jenkins BW, Addison C, Wilson G, Liu J, Fortune M, Robinson K, White M, Sarpong D (2011) Association of the joint effect of menopause and hormone replacement therapy and cancer in African American women: the Jackson Heart Study. Int J Environ Res Public Health 8(6):2491–2504.  https://doi.org/10.3390/ijerph8062491 CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Arrigo RT, Kalanithi P, Cheng I, Alamin T, Carragee EJ, Mindea SA, Park J, Boakye M (2011) Predictors of survival after surgical treatment of spinal metastasis. Neurosurgery 68(3):674–681.  https://doi.org/10.1227/NEU.0b013e318207780c.(discussion 681).CrossRefPubMedGoogle Scholar
  31. 31.
    Lee BH, Kim TH, Chong HS, Moon ES, Park JO, Kim HS, Kim SH, Lee HM, Cho YJ, Kim KN, Moon SH (2013) Prognostic factor analysis in patients with metastatic spine disease depending on surgery and conservative treatment: review of 577 cases. Ann Surg Oncol 20(1):40–46.  https://doi.org/10.1245/s10434-012-2644-4 CrossRefPubMedGoogle Scholar
  32. 32.
    Bollen L, de Ruiter GC, Pondaag W, Arts MP, Fiocco M, Hazen TJ, Peul WC, Dijkstra PD (2013) Risk factors for survival of 106 surgically treated patients with symptomatic spinal epidural metastases. Eur Spine J 22(6):1408–1416.  https://doi.org/10.1007/s00586-013-2726-4 CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Tokuhashi Y, Matsuzaki H, Oda H, Oshima M, Ryu J (2005) A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine 30(19):2186–2191CrossRefGoogle Scholar
  34. 34.
    Coleman RE, McCloskey EV (2011) Bisphosphonates in oncology. Bone 49(1):71–76.  https://doi.org/10.1016/j.bone.2011.02.003 CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Orthopaedic Oncology Center, Department of Orthopaedics,Changzheng HospitalSecond Military Medical UniversityShanghaiChina

Personalised recommendations